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Cell suspension cultures were established using soft, friable callus derived from nucellar tissue of ‘Hass’ 
avocado (Persea americana Mill.) seed from fruit harvested 190 days after full bloom. Cell cultures were 
maintained in liquid medium supplemented with naphthalene acetic acid (NAA), isopentenyl adenine (iP) 
and sucrose and sub-cultured at 14 day intervals. Growth was typically sigmoidal with a lag phase of 7 
days followed by an exponential phase of approximately 14 days. Mevastatin, an inhibitor of 3-hydroxy-3-
methylglutaryl coenzyme A reductase (HMGR, EC 1.1.1.34) was used to probe the contribution of 
metabolites of the isoprenoid pathway for avocado cell growth. Treatment with mevastatin inhibited cell 
growth and caused loss of cell viability. Inhibition of cell growth was transient and at all concentrations of 
mevastatin tested, recovery was evident within 17 days. The arrest of cell growth by 1 and 40 µmol/L 
mevastatin was negated when this inhibitor of HMGR was supplied in the presence of either 
mevalonolactone (MVL) or farnesyl diphosphate (FDP). By comparison, co-treatment of cells supplied 1 
µmol/L mevastatin with stigmasterol showed little or no response whereas at 40 µmol/L mevastatin, 
stigmasterol induced partial recovery of cell growth. The results indicate a requirement for mevalonic acid 
(MVA) and cytosolic isoprenoid biosynthesis, in particular FDP, for avocado cell growth and support the 
hypothesis that appearance of the small-fruit phenotype in ‘Hass’ is inextricably linked to activity of 
HMGR. 
 





‘Hass’ avocado (Persea americana Mill.) which produces 
both normal and phenotypically small fruit, presents an ideal 
system in which to investigate the underlying mechanisms 
contributing to the metabolic control of fruit growth. 
Furthermore, unlike most other fruits, cell division in 
avocado continues throughout development albeit at a 
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Unfortunately, detailed biochemical and molecular studies of 
fruit growth in subtropical tree crops such as avocado, are 
limited by seasonality and geographical location of the 
species. One way to overcome this limitation is to establish 
cell cultures that can be maintained in liquid suspension and 
which mimic the response of the parent tissue to chemical 
and environmental stimuli. 
In attempting to elucidate the causal factors responsible 
for the appearance of the small-fruit variant in ‘Hass’ 
avocado, the following information has been obtained using 
intact fruit as the experimental system. Firstly, growth of the 
small-fruit variant is limited by cell number (Cowan et al., 







those reported recently for melon (Higashi et al., 1999). 
Secondly, cessation of growth in the small-fruit variant is 
associated with early senescence and death of the seed 
coat and a reduction in symplastic solute transport (Moore-
Gordon et al., 1998; Richings et al., 2000). Thirdly, the 
characteristics mentioned above are phenocopied when 
normal fruit are treated with either abscisic acid (ABA) or 
inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A 
reductase (HMGR, EC 1.1.1.34). Interestingly, the small-
fruit variant has elevated endogenous abscisic acid (ABA) 
and reduced microsomal HMGR activity (Cowan et al., 
1997), characteristics that are simulated by exogenous 
glucose (Richings et al., 2000). Since ABA-induced 
retardation of growth, and inhibition of HMGR activity are 
negated by co-treatment with cytokinin, and to a lesser 
extent stigmasterol, it was proposed that appearance of the 
small-fruit phenotype might be the result of an altered 
cytokinin/ABA ratio which affected HMGR activity and 
phytosterol production during fruit growth (Cowan et al., 
1997; Moore-Gordon et al., 1998; Cowan et al., 2001). The 
recent demonstration that cytokinin stimulates ABA 
catabolism in competent tissue provides partial support for 
this proposal (Cowan et al., 1999). In brief, it is 
hypothesized that increased ABA is central to the 
appearance of small ‘Hass’ fruit and that ABA influences at 
least four areas of cell function to depress cell cycle activity 
and fruit growth. These include: 1) the cytokinin/ABA ratio; 
2) initiation of ABA signal transduction; 3) reduced 
symplastic solute transport; and, 4) retardation of cell 
division cycle activity. Clearly, the interactions alluded to do 
not occur in isolation and together they comprise a complex 
system, the underlying molecular mechanism of which has 
still to be elucidated. 
It is generally believed that developing seeds are the 
source of regulatory molecules that modulate cell division 
and fruit growth. As a first priority, therefore, we sought to 
establish a cell suspension culture from ‘Hass’ avocado 
seed with which to study more detailed aspects of avocado 
fruit growth. Additionally, an earlier report indicated that 
mevastatin-induced retardation of fruit growth arose as a 
result of a reduction in HMGR activity, which it was 
proposed, contributed to the arrest of cell division (Cowan et 
al., 1997). To confirm this proposal we investigated the 
effect of mevastatin on cell growth in vitro and, determined 
whether intermediates in the isoprenoid biosynthetic 
pathway could restore cell division in vitro as was recently 
shown for avocado fruit treated in vivo (Richings et al., 
2000). The results are discussed in terms of the relationship 
between isoprenoid biosynthesis and cell division in 
avocado seed cell suspension cultures. 
 
 
MATERIALS AND METHODS 
 
Growth regulators, isoprenoid compounds and inhibitors  
 
α-Naphthalene acetic acid (NAA), 6-(γ,γ-dimethylallylamino)-purine 
(isopentenyl    adenine;    iP),    mevalonolactone     (MVL),     arnesyl  




diphosphate (FDP), fluorescein diacetate (FDA), stigmasterol and 
mevastatin (compactin) were purchased from Sigma Chemical Co., St 
Louis, MO, USA. 
 
 
Plant material and callus induction  
 
Phenotypically normal ‘Hass’ avocado fruit were harvested 190 days 
after full bloom during the linear phase of growth from 9 year-old trees 
grafted on clonal ‘Duke 7’ rootstock and growing in a commercial 
orchard on Bounty Farm in the KwaZulu-Natal midlands, South Africa. 
Fruit was washed with Extran (Merck, Darmstadt, Germany) and 
immersed in 3.5% sodium hypochlorite containing several drops of 
Tween 20 for 15 min, followed by 80% ethanol for 1 min, after which 
fruit was rinsed in three changes of ultra pure water. Seeds were 
dissected from surface-sterilized fruit and sectioned into explants of 
approximately 100 mg fresh weight. Explants were cultivated on 0.8% 
agar containing MSB media (Murashige and Skoog, 1962; Gamborg et 
al., 1968) supplemented with NAA (5 mg/L), iP (5 mg/L) and 3% 
sucrose and produced a substantial mass of proliferated cells. Culture 
vessels were incubated at room temperature and under continuous 
illumination from laboratory lights. 
 
 
Cell suspension initiation and maintenance 
 
Cell suspensions were initiated by transferring approximately 5 g ‘wet’ 
callus, derived from nucellar tissue of ‘Hass’ avocado seed, to 20 mL 
liquid MSB medium supplemented with NAA (5 mg/L), iP (1 mg/L) and 
3% sucrose. Suspension cultures were maintained on a rotary shaker 
(120 rpm) in 250 mL Erlenmyer flasks at 27oC under a 16 h light (35 
µmol m-2 s-1) / 8 h dark photoperiod and sub-cultured every 14 days. 
Cell aggregates were excluded during subculture by removal of 10 mL 
suspension, using a thin-bored pipette, and transfer to 10 mL fresh 
MSB medium at intervals of 14 days. Growth was monitored by 
measuring the change in cell number (see below). 
 
 
Application of chemicals 
 
Cell suspensions were initiated as described above. The effect of 
mevastatin on cell growth was determined by addition of this inhibitor in 
the range 0.01-40 µmol/L (prepared in dimethyl sulfoxide, DMSO) prior 
to the exponential phase of growth (ca. 10 days after culture initiation).  
At the intervals specified in Results, a 50 µL aliquot was removed from 
each replicate, pooled to create a treatment sample, stained with FDA 
(10 µg/mL) and examined using UV light  (450-490 nm) through a Zeiss 
Axiophot microscope to qualitatively monitor cell viability. Cell number 
was monitored as described below. Each treatment was replicated five 
times and the experiment was repeated at least two-times.  
For studies on the effect of mevastatin plus isoprenoid compounds 
on cell growth, MVL (6 mmol/L), FDP (10 µmol/L) and stigmasterol (10 
µmol/L), prepared in DMSO, were added to cell cultures together with 1 
µmol/L or 40 µmol/L mevastatin after 7 days of cell growth and changes 
in cell number monitored. Results are from at least two experiments in 
which the treatments were replicated 6 times. 
 
 
Determination of cell number 
 
Cell number was determined by adding 100 µL chromic acid (8 % (w/v) 
chromic trioxide) to a 50 µL aliquot of cell suspension followed by 
incubation at 70oC for 15 min. After dilution, 1 mL was transferred to a 
counting chamber (Sedgewick-Rafter Cell S50, ProSciTech, 
Thuringowa, Australia) and the number of cells in 20 random squares 
determined using a Zeiss KF2 light microscope. All values were 
corrected for dilution. 
 
  






Properties and dynamics of the ‘Hass’ avocado cell 
suspension  
 
Cultures selected for use in the present study were of 
nucellar tissue from embryo callus derived from seed of 
‘Hass’ avocado fruit harvested 190 days after full bloom. For 
sustained cell division, an exogenous supply of NAA, iP and 
sucrose was necessary (data not shown). Cell suspension 
growth followed a sigmoidal curve with a lag phase of ca. 7 
days and an exponential phase of ca. 12–15 days followed 
by a stationary phase (Figure 1). 
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Figure 1. Population dynamics of cells derived from ‘Hass’ avocado 
seed callus incubated in MSB liquid medium containing NAA (5 mg/L) 
and iP (1 mg/L). Cells number and viability were determined at each 
time interval as described in Materials and Methods. Data were 
collected from nine replicates. The fitted curve is a three-order 




To investigate the requirement for HMGR and hence 
cytosolic isoprenoid biosynthesis in avocado cell growth, the 
response of cell suspensions to increasing concentrations 
of mevastatin (a specific inhibitor of HMGR) was determined 
and the results are presented in Figure 2. Mevastatin 
inhibited cell growth within three days of application 
irrespective of concentration and appeared to do so in a 
dose-dependent manner. By day 14, cells treated with 0.01 
µmol/L mevastatin had recovered and showed positive 
growth while by day 17, the 0.1 µmol/L and 1 µmol/L 
mevastatin-treated cells displayed positive growth. It is 
interesting that all treatments caused a severe decline in 
viable cell number in the 7-day period following application. 
Thereafter, mevastatin-treated cell cultures recovered, 
albeit at different rates. Only cells treated with 10 and 40 
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Figure 2. Growth response of ‘Hass’ avocado seed cell suspension 
cultures to increasing concentrations of mevastatin (0 - 40 µmol/L) 
added at the start of exponential growth (7 days after sub-culture 
initiation). Cell number was determined at the specified intervals and 
the response to mevastatin treatment expressed as percentage change 





inoculation density. At all stages during the experiment, 
growth of untreated cells was significantly (P<0.05) greater 
than those supplied mevastatin.  
Although cells treated with 0.01µmol/L mevastatin 
recovered fastest these did not necessarily display a growth 
response that was significantly greater (P<0.05) than that 
observed for cells treated with higher mevastatin 
concentrations (Figure 2). Figure 3 shows the results of 
FDA staining for cell viability in cultures 17 days after 
application of mevastatin. The micrographs give a clear 
indication of loss of cell viability in response to increasing 
concentrations of mevastatin. Generally, control cultures 
and, 0.01 and 0.1 µmol/L mevastatin-treated cultures 
contained a large proportion of viable cells (Figure 3A-C). At 
1 µmol/L mevastatin, however, loss in cell integrity was 
clearly evident (Figure 3D). Analysis of FDA-stained cells 
from cultures supplied 10 and 40 µmol/L mevastatin 
revealed an almost total loss of viability (Figure 3E, F). 
 
 
Effect of isoprenoid compounds on mevastatin-induced 
inhibition of cell growth  
 
In order to investigate the effect of isoprenoid compounds 
on the growth of mevastatin-treated cells, two 
concentrations of mevastatin were selected; 1 µmol/L to 
minimize non-specific effects, and 40 µmol/L, for 
comparative purposes. Mevalonolactone, FDP and 
stigmasterol were formulated in solutions containing either 1 
or 40 µmol/L mevastatin respectively. After addition to cell 








                     




Figure 3. Determination of viability of mevastatin-treated cells. Aliquots 
of cells were harvested 17 days after treatment, stained with FDA (10 
µg/mL) for 1 min, viewed under UV (450-490 nm) light (maximum 
exposure, 5 min) and fluorescence recorded digitally. Images were 
captured using a Panasonic WV-CP450 digital camera and AnalySIS 
version 3.0, image analysis software (Soft Imaging System, Munster, 
Germany). Note: differences in background are due to alterations in 
gain (increase) and saturation (decrease) to enhance contrast between 
fluorescing and non- or weakly fluorescing cells. Experimental details 
are as described for Fig. 2. (A) Control; (B) 0.01 µmol/L mevastatin; (C) 
0.1 µmol/L mevastatin; (D) 1.0 µmol/L mevastatin; (E) 10 µmol/L 




throughout the incubation period. For ease of presentation, 
only changes in cell number are shown (Fig. 4A, B). 
Treatment of avocado cell suspensions with mevastatin (1 
µmol/L) plus MVL or FDP negated the inhibitory effect of 
mevastatin on cell growth (Figure 4A). By comparison, 
stigmasterol had little or no effect on inhibition of cell growth 
induced by mevastatin at 1 µmol/L. The response of cell 
cultures treated with mevastatin (40 µmol/L) in the presence 
or absence of MVL (or FDP, or stigmasterol) is shown in 
Figure 4B.  MVL, FDP, and stigmasterol negated the 
inhibitory effect of mevastatin on cell growth and the order 





The arrest of cell growth by inhibitors of HMGR activity is 
not novel and the results described for avocado cell 
suspensions in the present investigation confirm and extend 
what has previously been demonstrated using cell cultures 
from Catharanthus roseus (Imbault et al., 1996), 
Lycopersicon esculentum (Jelesko et al., 1999), Nicotiana 
tabacum (Crowell and Salaz, 1992; Morehead et al., 1995; 
Hemmerlin and Bach, 1998) and Solanum xanthocarpum 
(Josekutty, 1998). Although protoplasts have been isolated 
from nonmorphogenic avocado callus (Blickle et al., 1986), 
avocado mesocarp (Percival et al., 1991), and from 
embryogenic suspension cultures (Witjaksono et al., 1998) 
there are no reports on the development of cell suspension 
cultures from avocado seed tissue, and the effects of 
inhibitors of HMGR on avocado cell growth have never been 
documented. Furthermore, this study reports for the first 
time the ability of FDP to negate the arrest of plant cell 
growth by an inhibitor of HMGR. 
FDA was used to demonstrate loss of cell viability in 
response to inhibition of HMGR by mevastatin. While cell 
growth and viability data corresponded, it is apparent that 
the increase in cell viability at 10 and 40 µmol/L mevastatin, 
as shown in Figure 2, was not reflected in the micrograph 
data as might have been expected. FDA  is non-polar and 
permeates freely across the intact plasma membrane. 
Hydrolysis of FDA within the cell by non-specific esterases 
yields fluorescein which cannot cross the lipophilic plasma 
membrane. Fluorescein thus accumulates and  fluoresces  
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Figure 4. Response of ‘Hass’ avocado cell suspensions to co-
treatment with either 1µmol/L (A) or 40 µmol/L (B) mevastatin with or 
without MVL (6 mmol/L), FDP (10 µmol/L) and stigmasterol (STIG, 10 
µmol/L).  Experiments were initiated 7 days after inoculation of cells 
into fresh medium. At the specified intervals, an aliquot was removed 
from each treatment and cell number and viability determined as 
described in Materials and Methods. Results are expressed as, change 





when exposed to UV-light (Rotman and Papermaster, 1966; 
Larkin, 1976). Perturbations in membrane integrity, or the 
presence of conditions which damage the cell without 
disrupting its morphological integrity (such as aging or 
treatment with surface agents) result in reduced, or a lack of 
fluorescence (Rotman and Papermaster, 1966). The 
isoprenoid pathway is integral to cell survival and any 
disruption of this pathway may cause a cascade of events 
affecting many areas of cell function. Inhibition of HMGR 
may result in conditions where FDA is not metabolized 
and/or fluorescein not retained in cells. This might explain 
the lack of fluorescence observed in cells treated with high 
concentrations of mevastatin, which has been shown to 
cause cell death (Hemmerlin and Bach, 1998). 
Nevertheless, the above results do indicate that sub-lethal 





while at higher concentrations (10-40 µmol/L) loss of cell 
viability and inhibition of growth occur. 
Since MVA is the immediate product of the reaction 
inhibited by mevastatin, and is subsequently phosphorylated 
and decarboxylated to generate isopentenyl diphosphate, 
the precursor to all higher isoprenoids (Chappell, 1995), it is 
not surprising that addition of MVL reversed the effects of 
mevastatin. The identical response has been observed in 
other cell culture systems (Crowell and Salaz, 1992; Imbault 
et al., 1996; Morehead et al., 1995) and there are clear 
indications that MVA is required for cell cycle progression 
(Hemmerlin and Bach, 1998; Jelesko et al., 1999). By 
comparison, the reversal of mevastatin-induced inhibition of 
cell growth by FDP, which has not previously been reported, 
poses several questions particularly as FDP restores both 
growth and HMGR activity in seed of mevastatin-treated 
fruit (Richings et al., 2000).  
FDP is not only a precursor to higher isoprenoids (e.g. 
sterols, sesquiterpenes) but also serves as a substrate for 
protein farnesylation. Furthermore, its immediate derivative, 
geranylgeranyl diphosphate (GGPP), can also act as a 
substrate for protein prenylation. Protein prenylation is a 
post-translational event, the products of which play key roles 
in signal transduction, cytoskeletal and nuclear architecture, 
membrane transport and progression through the cell cycle. 
Indeed, prenylated proteins have been documented in 
plants and the respective farnesyl- and geranylgeranyl-
transferase activities described (Nambara and McCourt, 
1999; Rodríguez-Concepción et al., 1999). Three different 
prenyltransferases are associated with protein prenylation in 
animals and yeasts – a single farnesyl transferase (Ftase) 
and two geranylgeranyl transferases (GGTase-I and II). In 
plants, the presence of Ftase and GGTase-I and GGTase-II 
(Rab-GGTase) has been confirmed (Randall et al., 1993; 
Schmitt et al., 1996; Yalovsky et al., 1996). While there is 
little information on plant GGTases, Ftase activity in plants 
has been well characterized. Studies by Qian et al. (1996) 
revealed that farnesylation of proteins is involved in the 
control of cell cycle activity. Thus, manumycin, an Ftase 
inhibitor completely blocked the entry of tobacco BY-2 cells 
into mitosis. Similarly, inhibitors of both HMGR and Ftase 
impaired growth of cultured tobacco cells (Morehead et al., 
1996). The process of protein prenylation is not considered 
to be regulatory because the covalent attachment of FDP or 
GGPP is non-reversible (Rodríguez-Concepción et al., 
1999). It might, therefore, be reasonable to suggest that 
HMGR inhibition causes a reduction in available MVA for 
FDP synthesis leading to decreased protein farnesylation 
and, consequently, limited cell division. The addition of 
exogenous FDP reverses this affect by satisfying Ftase 
substrate demand. 
Of course, FDP might be converted to GGPP, which is 
then used as the substrate for protein prenylation in 
avocado cells. This is particularly so given that exogenous 
application of GGPP negated mevastatin-induced inhibition 
of microsomal HMGR activity and avocado fruit growth 







GGPP is an essential metabolite of the mevalonate cascade 
in animals and is required for cell cycle progression 
(Tatsuno et al., 1997). 
Another possible reason for the FDP-induced elevated 
growth response of avocado cells may be that factors 
limiting for cell division are derived from FDP. In the cultures 
used, cytokinin was not limiting since the media contained 
iP. Therefore, cytokinin-regulated complexes in the cell 
division cycle were presumably active. Responses of cells to 
the addition of different concentrations of mevastatin, 
however, revealed a transient reduction in cell division 
before recovery. If iP was present, what caused this 
reduction in cell growth? Sterols are derivatives of FDP and 
synthesized from squalene, which reverses mevinolin (a 
mevastatin analogue)-induced inhibition of cell growth 
(Josekutty, 1998). Cell division activity requires a significant 
level of sterol biosynthesis (Chappell, 1995). Narita and 
Gruissem (1989) found that early fruit development in 
tomato was sensitive to mevinolin whereas carotenoid 
biosynthesis continued. In explaining this, it was suggested 
that HMGR activity might be limiting only for sterol 
biosynthesis, which would result in less cell division and 
reduced fruit development (Gillaspy et al., 1993). 
Furthermore, Cowan et al. (1997) showed that mevastatin-
treated avocado fruit accumulated ABA. It is well 
established that high levels of ABA disrupt membrane lipid 
integrity and that phytosterols inhibit this action (Stillwell et 
al., 1989). While ABA content was not monitored following 
addition of mevastatin to avocado cell cultures, it is 
conceivable that a rise in ABA with a concomitant reduction 
in sterol biosynthesis, due to the inhibition of HMGR, would 
disrupt membrane integrity and result in decreased cell 
division and even cell death (Hemmerlin and Bach, 1998). 
The reestablishment of growth after addition of FDP to 
mevastatin-treated cells could be explained in part, by 
restoration of sterol biosynthesis and membrane integrity. 
In conclusion, we believe that the further elucidation of 
spatial and temporal regulatory components involved in 
mediating cell division in the avocado seed suspension 
culture system may lead to a greater understanding of the 
biochemical and molecular processes involved in fruit 
growth and the physiological problems associated with this 
developmental programme. Furthermore, our results 
support the notion that intermediates in the isoprenoid 
biosynthetic pathway serve as end products essential for 
normal cell growth and function (Masferrer et al., 2002).  It 
must however, be noted that growth of the ‘Hass’ small-fruit 
phenotype is limited by cell division in the mesocarp 
(Schroeder, 1953; Cowan et al., 1997). Whether cell 
suspensions from avocado mesocarp tissue respond 
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